This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by Seqirus Vaccines Ltd., USA.
Reference
Pelton SI, et al. A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season. Vaccine : 30 Mar 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.03.054
Rights and permissions
About this article
Cite this article
Adjuvanted vs high-dose trivalent influenza vaccines: comparable clinical and economic benefits among elderly in the US. PharmacoEcon Outcomes News 876, 3 (2021). https://doi.org/10.1007/s40274-021-7617-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7617-z